company background image
LIBRAINFU logo

Libra Infusions DSE:LIBRAINFU Stock Report

Last Price

৳666.50

Market Cap

৳1.5b

7D

7.9%

1Y

48.7%

Updated

22 Jun, 2024

Data

Company Financials

Libra Infusions Limited

DSE:LIBRAINFU Stock Report

Market Cap: ৳1.5b

LIBRAINFU Stock Overview

Manufactures and sells injectable intravenous fluids in Bangladesh.

LIBRAINFU fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

Libra Infusions Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Libra Infusions
Historical stock prices
Current Share Price৳666.50
52 Week High৳1,146.67
52 Week Low৳445.73
Beta0
11 Month Change0.73%
3 Month Change-15.48%
1 Year Change48.66%
33 Year Change82.07%
5 Year Change11.90%
Change since IPO3,057.11%

Recent News & Updates

Recent updates

Shareholder Returns

LIBRAINFUBD PharmaceuticalsBD Market
7D7.9%4.2%3.2%
1Y48.7%-20.8%-24.3%

Return vs Industry: LIBRAINFU exceeded the BD Pharmaceuticals industry which returned -20.8% over the past year.

Return vs Market: LIBRAINFU exceeded the BD Market which returned -24.3% over the past year.

Price Volatility

Is LIBRAINFU's price volatile compared to industry and market?
LIBRAINFU volatility
LIBRAINFU Average Weekly Movement5.3%
Pharmaceuticals Industry Average Movement6.8%
Market Average Movement5.4%
10% most volatile stocks in BD Market7.6%
10% least volatile stocks in BD Market3.4%

Stable Share Price: LIBRAINFU has not had significant price volatility in the past 3 months.

Volatility Over Time: LIBRAINFU's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1976n/aRoushon Alamlibragroupbd.com/libra_infusions.php

Libra Infusions Limited manufactures and sells injectable intravenous fluids in Bangladesh. Its products are used in medical situations, including diuresis, surgical intervention, intoxication, sodium deficit, infections, and weakness. The company was formerly known as Libra Pharmaceutical Limited and changed its name to Libra Infusions Limited in 1999.

Libra Infusions Limited Fundamentals Summary

How do Libra Infusions's earnings and revenue compare to its market cap?
LIBRAINFU fundamental statistics
Market cap৳1.50b
Earnings (TTM)৳1.58m
Revenue (TTM)৳197.03m

0.0x

P/E Ratio

0.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
LIBRAINFU income statement (TTM)
Revenue৳197.03m
Cost of Revenue৳119.14m
Gross Profit৳77.89m
Other Expenses৳76.30m
Earnings৳1.58m

Last Reported Earnings

Jun 30, 2019

Next Earnings Date

n/a

Earnings per share (EPS)0
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0.0%

How did LIBRAINFU perform over the long term?

See historical performance and comparison

Dividends

0.2%

Current Dividend Yield

n/a

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.